GlassScriptPhysician profile
Michelle Jordan
NPI 1700815214
$20,890.82
in general payments reported to CMS, 2019-2025
14 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $901 · 2021: $2,470 · 2022: $4,280 · 2023: $350 · 2024: $633 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11,290.43 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $8,529.24 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $269.00 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $189.69 | 2022-2024 | Otezla |
| Ethicon US, LLC | $158.85 | 2021-2024 | Enseal, Harmonic, Surgicel Nu-Knit |
| Elucent Medical | $156.13 | 2024 | |
| Atricure, INC. | $101.85 | 2024 | |
| Medtronic USA, INC. | $46.88 | 2019 | |
| Abbott Laboratories | $38.53 | 2025 | Cardiomems |
| Mallinckrodt Enterprises LLC | $29.89 | 2019 | |
| Astellas Pharma US INC | $28.67 | 2025 | Veozah |
| Janssen Pharmaceuticals, INC | $22.32 | 2019 | |
| Advanced Respiratory, INC | $15.52 | 2019 | |
| Sunovion Pharmaceuticals INC. | $13.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.